Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$7.77 - $10.61 $1,554 - $2,122
200 Added 1.48%
13,700 $145,000
Q4 2023

Feb 13, 2024

BUY
$6.53 - $8.23 $88,155 - $111,105
13,500 New
13,500 $108,000
Q2 2022

Aug 11, 2022

SELL
$7.06 - $23.63 $71,962 - $240,860
-10,193 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$21.6 - $27.79 $17,064 - $21,954
790 Added 8.4%
10,193 $233,000
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $18,400 - $23,208
-800 Reduced 7.84%
9,403 $260,000
Q3 2021

Nov 16, 2021

BUY
$25.04 - $30.06 $61,348 - $73,647
2,450 Added 31.6%
10,203 $284,000
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $9,682 - $11,543
353 Added 4.77%
7,753 $228,000
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $158,138 - $254,412
7,400 New
7,400 $235,000
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $35,712 - $48,312
-2,400 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $31,944 - $49,224
2,400 New
2,400 $44,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.